Cumberland Pharmaceuticals, Inc. (CPIX)
6.66
+0.86
(+14.83%)
USD |
NASDAQ |
Nov 18, 16:00
6.55
-0.11
(-1.65%)
After-Hours: 20:00
Cumberland Pharmaceuticals EPS Diluted (Quarterly) : -0.19 for Sept. 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | -0.19 |
| June 30, 2026 | -0.2854 |
| March 31, 2026 | -0.2199 |
| December 31, 2025 | -0.0944 |
| September 30, 2025 | -0.1297 |
| June 30, 2025 | -0.0495 |
| March 31, 2025 | 0.0824 |
| December 31, 2024 | -0.1363 |
| September 30, 2024 | -0.1099 |
| June 30, 2024 | -0.0769 |
| March 31, 2024 | -0.138 |
| December 31, 2023 | -0.4442 |
| September 30, 2023 | -0.0735 |
| June 30, 2023 | 0.0599 |
| March 31, 2023 | 0.0132 |
| December 31, 2022 | -0.1695 |
| September 30, 2022 | -0.0282 |
| June 30, 2022 | -0.0909 |
| March 31, 2022 | -0.0943 |
| December 31, 2021 | -0.26 |
| September 30, 2021 | -0.0709 |
| June 30, 2021 | 0.0813 |
| March 31, 2021 | 0.0109 |
| December 31, 2020 | -0.0588 |
| September 30, 2020 | -0.0318 |
| Date | Value |
|---|---|
| June 30, 2020 | -0.0602 |
| March 31, 2020 | -0.0693 |
| December 31, 2019 | -0.0631 |
| September 30, 2019 | -0.1271 |
| June 30, 2019 | -0.0354 |
| March 31, 2019 | -0.0048 |
| December 31, 2018 | -0.143 |
| September 30, 2018 | -0.1055 |
| June 30, 2018 | -0.046 |
| March 31, 2018 | -0.1516 |
| December 31, 2017 | -0.05 |
| September 30, 2017 | -0.05 |
| June 30, 2017 | -0.32 |
| March 31, 2017 | -0.08 |
| December 31, 2016 | -0.05 |
| September 30, 2016 | 0.01 |
| June 30, 2016 | -0.003 |
| March 31, 2016 | -0.02 |
| December 31, 2015 | 0.01 |
| September 30, 2015 | 0.01 |
| June 30, 2015 | 0.02 |
| March 31, 2015 | 0.0027 |
| December 31, 2014 | 0.04 |
| September 30, 2014 | 0.04 |
| June 30, 2014 | 0.04 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 1.510 |
| Corcept Therapeutics, Inc. | 1.010 |
| Veru, Inc. | -0.3032 |
| Johnson & Johnson | 0.0858 |
| Eli Lilly & Co. | 7.221 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -1.122M |
| Revenue (Quarterly) | 2.156M |
| Total Expenses (Quarterly) | 3.279M |
| Enterprise Value | 10.64M |
| Gross Profit Margin (Quarterly) | 49.33% |
| Profit Margin (Quarterly) | -52.04% |
| Earnings Yield | -11.86% |
| Normalized Earnings Yield | -11.54 |